Sequences

Sample result

A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.

Human insulin's gene

DNA → Patent DNA · Automatic (BLAST)

Download as Excel

Every list and the search record, one sheet each.

Query
INS · 333 lettersATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGACCCAGCCGCAGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGGGAACGAGGCTTCTTCTACACACCCAAGACCCGCCGGGAGGCAGAGGACCTGCAGGTGGGGCAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTGTACCAGCATCTGCTCCCTCTACCAGCTGGAGAACTACTGCAACTAG
Set
Public patent sequences: Patent DNA, snapshot 2026-11-05-c456f6bdba29
Ran
2026-11-12
Found
3,194 sequences, 1,584 publications, 1,066 families

BLAST can miss matches that an exact scan or Smith-Waterman finds.

Charts

Identity against coverage

3,194 hits by identity and query coverage. 3,194 with a date.

Has a date00101020203030404050506060707080809090100100Identity (%)Query coverage (%)
Show table
Hits by identity
BandHas a dateAll
100%382382
95 to 99.9%273273
90 to 94.9%264264
80 to 89.9%1,4061,406
70 to 79.9%863863
50 to 69.9%66
Hits by query coverage
BandHas a dateAll
100%176176
95 to 99.9%510510
90 to 94.9%22
80 to 89.9%1111
70 to 79.9%193193
50 to 69.9%5656
Under 50%2,2462,246

Hits by year

1,066 families by year of first publication, 1979 to 2026.

Has a dateFamilies020406080197919831987199119951999200320072011201520192023
Show table
Families by year of first publication
YearHas a dateAll
197922
198133
198266
198311
198455
198544
198677
198744
198833
198955
199088
199233
199544
199633
199744
199866
199988
20001111
20012222
20023636
20032828
20043333
20053434
20063333
20073535
20083535
20094242
20104242
20116363
20123939
20133737
20143434
20154747
20163737
20175656
20184343
20195353
20204242
20215757
20223838
20232727
20243333
20252828
202655

Where hits align on the query

The top 20 hits on INS, a query of 333 bases: 20 cover the whole query, none differs from it.

Aligned partDiffers from the queryINS · 333 bases150100150200250300333A57719.1AR102881.1AR300598.1AX384892.1BD224077.1CQ714703.1GX863382.1DL255436.1FU371285.1FU424096.1HI201319.1HI394608.1HI394612.1HD058979.1FW369459.1FW369460.1GZ866940.1HK527381.1HK527379.1HK527380.1
Show table
The top 20 hits on INS, positions on the query
HitQuery fromQuery toIdentityDiffers atGaps atN at
A57719.11333100.0%NoneNoneNone
AR102881.11333100.0%NoneNoneNone
AR300598.11333100.0%NoneNoneNone
AX384892.11333100.0%NoneNoneNone
BD224077.11333100.0%NoneNoneNone
CQ714703.11333100.0%NoneNoneNone
GX863382.11333100.0%NoneNoneNone
DL255436.11333100.0%NoneNoneNone
FU371285.11333100.0%NoneNoneNone
FU424096.11333100.0%NoneNoneNone
HI201319.11333100.0%NoneNoneNone
HI394608.11333100.0%NoneNoneNone
HI394612.11333100.0%NoneNoneNone
HD058979.11333100.0%NoneNoneNone
FW369459.11333100.0%NoneNoneNone
FW369460.11333100.0%NoneNoneNone
GZ866940.11333100.0%NoneNoneNone
HK527381.11333100.0%NoneNoneNone
HK527379.11333100.0%NoneNoneNone
HK527380.11333100.0%NoneNoneNone

Patents 1.6K

Columns
Tick the columns each row shows, then choose Show. The arrows move a column.

1,584 publications in 1,066 families match these filters.

  1. US 11369670-B22022-06-28

    Multiple malaria pre-erythrocytic antigens and their use in the elicitation of a protective immune response in a host

    Institut Pasteur and Centre National de la Recherche Scientifique

    Query Match 22.1%Identity 87.7%

    Best alignment

    Query 228 to 333, hit 6668 to 6773. Positions start at 1 and include both ends.

    Query  228 CCTGCAGCCCTTGGCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTG 287
               ||| ||| ||||||| ||||||| | ||| ||||||||| ||||| ||||| || |||||
    Hit   6668 CCTTCAGACCTTGGCACTGGAGGTGGCCCGGCAGAAGCGCGGCATCGTGGATCAGTGCTG 6727
    
    Query  288 TACCAGCATCTGCTCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
                |||||||||||||| |||||||| |||||||||||||||||||||
    Hit   6728 CACCAGCATCTGCTCTCTCTACCAACTGGAGAACTACTGCAACTAG 6773
    

    93 of 106 identical, no gaps.

  2. US 11649264-B22023-05-16

    Methods and products for genetic engineering

    Institut National De La Sante Et De La Recherche Medicale (INSERM), Centre National De La Recherche Scientifique (CNRS), Ecole Normale Superieure De Lyon and Universite De Claude Bernard Lyon 1

    Query Match 22.1%Identity 87.7%

    Best alignment

    Query 228 to 333, hit 6782 to 6887. Positions start at 1 and include both ends.

    Query  228 CCTGCAGCCCTTGGCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTG 287
               ||| ||| ||||||| ||||||| | ||| ||||||||| ||||| ||||| || |||||
    Hit   6782 CCTTCAGACCTTGGCACTGGAGGTGGCCCGGCAGAAGCGCGGCATCGTGGATCAGTGCTG 6841
    
    Query  288 TACCAGCATCTGCTCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
                |||||||||||||| |||||||| |||||||||||||||||||||
    Hit   6842 CACCAGCATCTGCTCTCTCTACCAACTGGAGAACTACTGCAACTAG 6887
    

    93 of 106 identical, no gaps.

  3. US 12049480-B22024-07-30

    Methods and products for genetic engineering

    Institut National de la Sante et de la Recherche Medicale (INSERM) et al

    Query Match 22.1%Identity 87.7%Family of 3

    Best alignment and family

    Query 228 to 333, hit 6782 to 6887. Positions start at 1 and include both ends.

    Query  228 CCTGCAGCCCTTGGCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTG 287
               ||| ||| ||||||| ||||||| | ||| ||||||||| ||||| ||||| || |||||
    Hit   6782 CCTTCAGACCTTGGCACTGGAGGTGGCCCGGCAGAAGCGCGGCATCGTGGATCAGTGCTG 6841
    
    Query  288 TACCAGCATCTGCTCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
                |||||||||||||| |||||||| |||||||||||||||||||||
    Hit   6842 CACCAGCATCTGCTCTCTCTACCAACTGGAGAACTACTGCAACTAG 6887
    

    93 of 106 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  4. US 12173290-B22024-12-24

    Materials and methods for controlling gene editing

    CRISPR THERAPEUTICS AG and BAYER HEALTHCARE LLC

    Query Match 22.1%Identity 87.7%

    Best alignment

    Query 228 to 333, hit 5375 to 5480. Positions start at 1 and include both ends.

    Query  228 CCTGCAGCCCTTGGCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTG 287
               ||| ||| ||||||| ||||||| | ||| ||||||||| ||||| ||||| || |||||
    Hit   5375 CCTTCAGACCTTGGCACTGGAGGTGGCCCGGCAGAAGCGCGGCATCGTGGATCAGTGCTG 5434
    
    Query  288 TACCAGCATCTGCTCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
                |||||||||||||| |||||||| |||||||||||||||||||||
    Hit   5435 CACCAGCATCTGCTCTCTCTACCAACTGGAGAACTACTGCAACTAG 5480
    

    93 of 106 identical, no gaps.

  5. JP 2025063185-A2025-04-15

    METHODS AND PRODUCTS FOR GENETIC ENGINEERING

    Applicants [Refer to the patent publication]

    Query Match 22.1%Identity 87.7%

    Best alignment

    Query 228 to 333, hit 6782 to 6887. Positions start at 1 and include both ends.

    Query  228 CCTGCAGCCCTTGGCCCTGGAGGGGTCCCTGCAGAAGCGTGGCATTGTGGAACAATGCTG 287
               ||| ||| ||||||| ||||||| | ||| ||||||||| ||||| ||||| || |||||
    Hit   6782 CCTTCAGACCTTGGCACTGGAGGTGGCCCGGCAGAAGCGCGGCATCGTGGATCAGTGCTG 6841
    
    Query  288 TACCAGCATCTGCTCCCTCTACCAGCTGGAGAACTACTGCAACTAG 333
                |||||||||||||| |||||||| |||||||||||||||||||||
    Hit   6842 CACCAGCATCTGCTCTCTCTACCAACTGGAGAACTACTGCAACTAG 6887
    

    93 of 106 identical, no gaps.

  6. JP 2025500874-A2025-01-15

    POLYCISTRONIC EXPRESSION OF GUT PEPTIDES

    MeiraGTx UK II Limited

    Query Match 21.9%Identity 100.0%

    Best alignment

    Query 1 to 73, hit 1 to 73. Positions start at 1 and include both ends.

    Query  1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
             ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
    
    Query 61 CCAGCCGCAGCCT 73
             |||||||||||||
    Hit   61 CCAGCCGCAGCCT 73
    

    73 of 73 identical, no gaps.

  7. DELIVERY SYSTEM FOR PORCINE SOMATOTROPIN

    COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION

    Query Match 21.6%Identity 100.0%

    Best alignment

    Query 1 to 72, hit 7 to 78. Positions start at 1 and include both ends.

    Query  1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
             ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    7 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 66
    
    Query 61 CCAGCCGCAGCC 72
             ||||||||||||
    Hit   67 CCAGCCGCAGCC 78
    

    72 of 72 identical, no gaps.

  8. US 6420345-A2002-07-16

    Methods and reagents for inhibiting angiogenesis

    Cell Genesys, Inc. and GPC Biotech Inc.

    Query Match 21.6%Identity 100.0%

    Best alignment

    Query 1 to 72, hit 1 to 72. Positions start at 1 and include both ends.

    Query  1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
             ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
    
    Query 61 CCAGCCGCAGCC 72
             ||||||||||||
    Hit   61 CCAGCCGCAGCC 72
    

    72 of 72 identical, no gaps.

  9. JP 2002527112-A2002-08-27

    Delivery system of porcine somatotropin

    COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION, UNIVERSITY OF WESTERN SYDNEY,PIG RESEARCH AND DEVELOPMENT CORP

    Query Match 21.6%Identity 100.0%

    Best alignment

    Query 1 to 72, hit 7 to 78. Positions start at 1 and include both ends.

    Query  1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
             ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    7 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 66
    
    Query 61 CCAGCCGCAGCC 72
             ||||||||||||
    Hit   67 CCAGCCGCAGCC 78
    

    72 of 72 identical, no gaps.

  10. JP 2002538182-A2002-11-12

    Method and reagent for inhibiting angiogenesis

    CELL GENESYS INC,GPC BIOTECH INC

    Query Match 21.6%Identity 100.0%

    Best alignment

    Query 1 to 72, hit 1 to 72. Positions start at 1 and include both ends.

    Query  1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
             ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
    
    Query 61 CCAGCCGCAGCC 72
             ||||||||||||
    Hit   61 CCAGCCGCAGCC 72
    

    72 of 72 identical, no gaps.

  11. US 6521602-A2003-02-18

    Anti-neoplastic compositions and uses thereof

    GPC Biotech Inc. and Cell Genesys, Inc.

    Query Match 21.6%Identity 100.0%

    Best alignment

    Query 1 to 72, hit 1 to 72. Positions start at 1 and include both ends.

    Query  1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
             ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
    
    Query 61 CCAGCCGCAGCC 72
             ||||||||||||
    Hit   61 CCAGCCGCAGCC 72
    

    72 of 72 identical, no gaps.

  12. US 6967089-A2005-11-22

    Delivery system for porcine somatotropin

    Commonwealth Scientific and Industrial Research Organisation, University of Western Sydney (Nepean) and Pig Research and Development Corporation

    Query Match 21.6%Identity 100.0%

    Best alignment

    Query 1 to 72, hit 7 to 78. Positions start at 1 and include both ends.

    Query  1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
             ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    7 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 66
    
    Query 61 CCAGCCGCAGCC 72
             ||||||||||||
    Hit   67 CCAGCCGCAGCC 78
    

    72 of 72 identical, no gaps.

  13. Vectors Conditionally Expressing Therapeutic Proteins, Host Cells Comprising the Vectors, and Uses Thereof

    INTREXON CORPORATION

    Query Match 21.6%Identity 100.0%Family of 5

    Best alignment and family

    Query 1 to 72, hit 1 to 72. Positions start at 1 and include both ends.

    Query  1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
             ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
    
    Query 61 CCAGCCGCAGCC 72
             ||||||||||||
    Hit   61 CCAGCCGCAGCC 72
    

    72 of 72 identical, no gaps.

    Family of 5

    Grouped by the same title and applicant. No priority claim is on record.

  14. JP 2013527753-A2013-07-04

    Vectors Conditionally Expressing Therapeutic Proteins, Host Comprising the Vectors, and Uses Thereof

    INTREXON CORPORATION

    Query Match 21.6%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 72, hit 1 to 72. Positions start at 1 and include both ends.

    Query  1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
             ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
    
    Query 61 CCAGCCGCAGCC 72
             ||||||||||||
    Hit   61 CCAGCCGCAGCC 72
    

    72 of 72 identical, no gaps.

    Family of 3

    Grouped by a shared priority claim, US 61/316792.

  15. EP 3155003-A22017-04-19

    AMYLOID BETA EXPRESSION CONSTRUCTS AND USES THEREFOR

    THE WHITEHEAD INST FOR BIOMEDICAL RES

    Query Match 21.6%Identity 100.0%

    Best alignment

    Query 1 to 72, hit 5 to 76. Positions start at 1 and include both ends.

    Query  1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
             ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    5 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 64
    
    Query 61 CCAGCCGCAGCC 72
             ||||||||||||
    Hit   65 CCAGCCGCAGCC 76
    

    72 of 72 identical, no gaps.

  16. JP 2017517269-A2017-06-29

    AMYLOID BETA EXPRESSION CONSTRUCTS AND USES THEREFOR

    WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH

    Query Match 21.6%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 72, hit 5 to 76. Positions start at 1 and include both ends.

    Query  1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
             ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    5 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 64
    
    Query 61 CCAGCCGCAGCC 72
             ||||||||||||
    Hit   65 CCAGCCGCAGCC 76
    

    72 of 72 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  17. RNA FOR CANCER THERAPY

    CUREVAC AG

    Query Match 21.6%Identity 100.0%

    Best alignment

    Query 1 to 72, hit 1 to 72. Positions start at 1 and include both ends.

    Query  1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
             ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
    
    Query 61 CCAGCCGCAGCC 72
             ||||||||||||
    Hit   61 CCAGCCGCAGCC 72
    

    72 of 72 identical, no gaps.

  18. JP 2018518946-A2018-07-19

    Modified UBE3A Gene for a Gene Therapy Approach for Angelman Syndrome

    University of South Florida

    Query Match 21.6%Identity 100.0%

    Best alignment

    Query 1 to 72, hit 1 to 72. Positions start at 1 and include both ends.

    Query  1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
             ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
    
    Query 61 CCAGCCGCAGCC 72
             ||||||||||||
    Hit   61 CCAGCCGCAGCC 72
    

    72 of 72 identical, no gaps.

  19. RNA FOR CANCER THERAPY

    CUREVAC AG

    Query Match 21.6%Identity 100.0%

    Best alignment

    Query 1 to 72, hit 1 to 72. Positions start at 1 and include both ends.

    Query  1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
             ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
    
    Query 61 CCAGCCGCAGCC 72
             ||||||||||||
    Hit   61 CCAGCCGCAGCC 72
    

    72 of 72 identical, no gaps.

  20. JP 2019526556-A2019-09-19

    RNA for cancer therapy

    CureVac AG

    Query Match 21.6%Identity 100.0%

    Best alignment

    Query 1 to 72, hit 1 to 72. Positions start at 1 and include both ends.

    Query  1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
             ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
    
    Query 61 CCAGCCGCAGCC 72
             ||||||||||||
    Hit   61 CCAGCCGCAGCC 72
    

    72 of 72 identical, no gaps.

  21. NOVEL YELLOW FEVER NUCLEIC ACID MOLECULES FOR VACCINATION

    CUREVAC AG

    Query Match 21.6%Identity 100.0%

    Best alignment

    Query 1 to 72, hit 1 to 72. Positions start at 1 and include both ends.

    Query  1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
             ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
    
    Query 61 CCAGCCGCAGCC 72
             ||||||||||||
    Hit   61 CCAGCCGCAGCC 72
    

    72 of 72 identical, no gaps.

  22. JP 2020528739-A2020-10-01

    Modified UBE3A Gene for a Gene Therapy Approach for Angelman Syndrome

    University of South Florida

    Query Match 21.6%Identity 100.0%

    Best alignment

    Query 1 to 72, hit 1 to 72. Positions start at 1 and include both ends.

    Query  1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
             ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
    
    Query 61 CCAGCCGCAGCC 72
             ||||||||||||
    Hit   61 CCAGCCGCAGCC 72
    

    72 of 72 identical, no gaps.

  23. JP 2022525564-A2022-05-17

    VECTOR AND METHOD FOR TREATING ANGELMAN SYNDROME

    PTC Therapeutics,University of South Florida,Edwin Weeber,Min Jung Kim, Liangxian Cao,Antonio Arulanandam,Kevin Nash

    Query Match 21.6%Identity 100.0%

    Best alignment

    Query 1 to 72, hit 1 to 72. Positions start at 1 and include both ends.

    Query  1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
             ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
    
    Query 61 CCAGCCGCAGCC 72
             ||||||||||||
    Hit   61 CCAGCCGCAGCC 72
    

    72 of 72 identical, no gaps.

  24. BCR TRANSGENIC MICE WITH A COMMON LEADER SEQUENCE

    BRISTOL-MYERS SQUIBB COMPANY

    Query Match 21.6%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 72, hit 1 to 72. Positions start at 1 and include both ends.

    Query  1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
             ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
    
    Query 61 CCAGCCGCAGCC 72
             ||||||||||||
    Hit   61 CCAGCCGCAGCC 72
    

    72 of 72 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  25. US 11524066-B22022-12-13

    Henipavirus vaccine

    CureVac SE

    Query Match 21.6%Identity 100.0%

    Best alignment

    Query 1 to 72, hit 1 to 72. Positions start at 1 and include both ends.

    Query  1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
             ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
    
    Query 61 CCAGCCGCAGCC 72
             ||||||||||||
    Hit   61 CCAGCCGCAGCC 72
    

    72 of 72 identical, no gaps.

  26. US 11534500-B22022-12-27

    Modified UBE3A gene for a gene therapy approach for angelman syndrome

    University of South Florida

    Query Match 21.6%Identity 100.0%

    Best alignment

    Query 1 to 72, hit 1 to 72. Positions start at 1 and include both ends.

    Query  1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
             ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
    
    Query 61 CCAGCCGCAGCC 72
             ||||||||||||
    Hit   61 CCAGCCGCAGCC 72
    

    72 of 72 identical, no gaps.

  27. US 11602557-B22023-03-14

    Bunyavirales vaccine

    Cure Vac SE

    Query Match 21.6%Identity 100.0%

    Best alignment

    Query 1 to 72, hit 1 to 72. Positions start at 1 and include both ends.

    Query  1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
             ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
    
    Query 61 CCAGCCGCAGCC 72
             ||||||||||||
    Hit   61 CCAGCCGCAGCC 72
    

    72 of 72 identical, no gaps.

  28. US 12201682-B22025-01-21

    Henipavirus vaccine

    CureVac SE

    Query Match 21.6%Identity 100.0%

    Best alignment

    Query 1 to 72, hit 1 to 72. Positions start at 1 and include both ends.

    Query  1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
             ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
    
    Query 61 CCAGCCGCAGCC 72
             ||||||||||||
    Hit   61 CCAGCCGCAGCC 72
    

    72 of 72 identical, no gaps.

  29. US 12397048-B22025-08-26

    Bunyavirales vaccine

    CureVac SE

    Query Match 21.6%Identity 100.0%

    Best alignment

    Query 1 to 72, hit 1 to 72. Positions start at 1 and include both ends.

    Query  1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
             ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
    
    Query 61 CCAGCCGCAGCC 72
             ||||||||||||
    Hit   61 CCAGCCGCAGCC 72
    

    72 of 72 identical, no gaps.

  30. PPT1 GENE THERAPY

    Spark Therapeutics, Inc

    Query Match 21.6%Identity 100.0%

    Best alignment

    Query 1 to 72, hit 1 to 72. Positions start at 1 and include both ends.

    Query  1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
             ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
    
    Query 61 CCAGCCGCAGCC 72
             ||||||||||||
    Hit   61 CCAGCCGCAGCC 72
    

    72 of 72 identical, no gaps.

  31. JP 2026511472-A2026-04-14

    PPT1 Gene Therapy

    Spark Therapeutics, Inc

    Query Match 21.6%Identity 100.0%

    Best alignment

    Query 1 to 72, hit 1 to 72. Positions start at 1 and include both ends.

    Query  1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
             ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
    
    Query 61 CCAGCCGCAGCC 72
             ||||||||||||
    Hit   61 CCAGCCGCAGCC 72
    

    72 of 72 identical, no gaps.

  32. WO 0125278-A12001-04-12

    C-peptide for the improved production of insulin and insulin analogues

    Aventis Pharma Deutschland GmbH (DE)

    Query Match 20.7%Identity 100.0%

    Best alignment

    Query 193 to 266, hit 13 to 86. Positions start at 1 and include both ends.

    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              |||||||||||||||||||||||||| ||||||||||||||||||||||| |||||||||
    Hit    13 CAGGTGGAGCTGGGCGGGGGCCCTGGCGCAGGCAGCCTGCAGCCCTTGGCGCTGGAGGGG 72
    
    Query 253 TCCCTGCAGAAGCG 266
              ||||||||||||||
    Hit    73 TCCCTGCAGAAGCG 86
    

    72 of 74 identical, no gaps.

  33. C-peptide for the improved production of insulin and insulin analogues

    Query Match 20.7%Identity 100.0%

    Best alignment

    Query 193 to 266, hit 13 to 86. Positions start at 1 and include both ends.

    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              |||||||||||||||||||||||||| ||||||||||||||||||||||| |||||||||
    Hit    13 CAGGTGGAGCTGGGCGGGGGCCCTGGCGCAGGCAGCCTGCAGCCCTTGGCGCTGGAGGGG 72
    
    Query 253 TCCCTGCAGAAGCG 266
              ||||||||||||||
    Hit    73 TCCCTGCAGAAGCG 86
    

    72 of 74 identical, no gaps.

  34. JP 2003511018-A2003-03-25

    C peptide improving the production of insulin and insulin analog

    AVENTIS PHARMA DEUTSCHLAND GMBH

    Query Match 20.7%Identity 100.0%

    Best alignment

    Query 193 to 266, hit 13 to 86. Positions start at 1 and include both ends.

    Query 193 CAGGTGGAGCTGGGCGGGGGCCCTGGTGCAGGCAGCCTGCAGCCCTTGGCCCTGGAGGGG 252
              |||||||||||||||||||||||||| ||||||||||||||||||||||| |||||||||
    Hit    13 CAGGTGGAGCTGGGCGGGGGCCCTGGCGCAGGCAGCCTGCAGCCCTTGGCGCTGGAGGGG 72
    
    Query 253 TCCCTGCAGAAGCG 266
              ||||||||||||||
    Hit    73 TCCCTGCAGAAGCG 86
    

    72 of 74 identical, no gaps.

  35. WO 9941390-A21999-08-19

    Expression vector for the production of dead proteins

    HUELS CHRISTOPH (DE)

    Query Match 19.4%Identity 95.8%

    Best alignment

    Query 1 to 72, hit 1 to 72. Positions start at 1 and include both ends.

    Query  1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
             ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
    
    Query 61 CCAGCCGCAGCC 72
             || |||  ||||
    Hit   61 CCGGCCCAAGCC 72
    

    69 of 72 identical, no gaps.

  36. JP 2002503474-A2002-02-05

    Expression vector for producing DEAD protein

    AVENTIS RESEARCH & TECHNOLOGIES GMBH & CO KG

    Query Match 19.4%Identity 95.8%

    Best alignment

    Query 1 to 72, hit 1 to 72. Positions start at 1 and include both ends.

    Query  1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
             ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
    
    Query 61 CCAGCCGCAGCC 72
             || |||  ||||
    Hit   61 CCGGCCCAAGCC 72
    

    69 of 72 identical, no gaps.

  37. US 6582691-A2003-06-24

    Expression vector for the production of dead proteins

    Aventis Research & Technologies GmbH & Co.

    Query Match 19.4%Identity 95.8%

    Best alignment

    Query 1 to 72, hit 1 to 72. Positions start at 1 and include both ends.

    Query  1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
             ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit    1 ATGGCCCTGTGGATGCGCCTCCTGCCCCTGCTGGCGCTGCTGGCCCTCTGGGGACCTGAC 60
    
    Query 61 CCAGCCGCAGCC 72
             || |||  ||||
    Hit   61 CCGGCCCAAGCC 72
    

    69 of 72 identical, no gaps.

  38. EP 3655006-A12020-05-27

    ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE

    AKSTON BIOSCIENCES CORP

    Query Match 19.4%Identity 88.8%Family of 14

    Best alignment and family

    Query 71 to 162, hit 56 to 147. Positions start at 1 and include both ends.

    Query  71 CCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCG 130
              |||| |||||||| |||||||||||||| ||||||||||||||||| || || |||||||
    Hit    56 CCTTCGTGAACCAGCACCTGTGCGGCTCCCACCTGGTGGAAGCTCTGTATCTCGTGTGCG 115
    
    Query 131 GGGAACGAGGCTTCTTCTACACACCCAAGACC 162
              | || || |||||||||||||| |||||| ||
    Hit   116 GCGAGCGGGGCTTCTTCTACACCCCCAAGGCC 147
    

    81 of 92 identical, no gaps.

    Family of 14

    Grouped by the same title and applicant. No priority claim is on record.

  39. US 11186623-B22021-11-30

    Ultra-long acting insulin-Fc fusion proteins and methods of use

    Akston Bioscience Corporation

    Query Match 19.4%Identity 88.8%

    Best alignment

    Query 71 to 162, hit 56 to 147. Positions start at 1 and include both ends.

    Query  71 CCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCG 130
              |||| |||||||| |||||||||||||| ||||||||||||||||| || || |||||||
    Hit    56 CCTTCGTGAACCAGCACCTGTGCGGCTCCCACCTGGTGGAAGCTCTGTATCTCGTGTGCG 115
    
    Query 131 GGGAACGAGGCTTCTTCTACACACCCAAGACC 162
              | || || |||||||||||||| |||||| ||
    Hit   116 GCGAGCGGGGCTTCTTCTACACCCCCAAGGCC 147
    

    81 of 92 identical, no gaps.

  40. Long-acting insulin gene construct and uses thereof

    POSTECH Research and Business Development Foundation

    Query Match 19.1%Identity 90.0%

    Best alignment

    Query 73 to 168, hit 1 to 96. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||| |||||||||||||| ||||||||||| || || ||||| ||||||||
    Hit     1 TTCGTCAACCAGCACCTGTGCGGCTCCCACCTGGTGGAGGCGCTGTACCTGGTGTGCGGA 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGCCGG 168
              || || |||||||||||||| |||||| ||||||||
    Hit    61 GAGCGCGGCTTCTTCTACACGCCCAAGGCCCGCCGG 96
    

    83 of 96 identical, no gaps.

  41. EP 0367163-A21990-05-09

    Process for producing an insulin precursor in streptomyces.

    HOECHST AKTIENGESELLSCHAFT

    Query Match 18.8%Identity 89.4%

    Best alignment

    Query 73 to 162, hit 16 to 105. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||| |||||||||||||| ||||| ||||| || |||||||| |||||||||
    Hit    16 TTCGTCAACCAGCACCTGTGCGGCTCGCACCTCGTGGAGGCCCTCTACCTGGTGTGCGGG 75
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACC 162
              || || |||||||||||||| |||||||||
    Hit    76 GAGCGCGGCTTCTTCTACACCCCCAAGACC 105
    

    79 of 90 identical, no gaps.

  42. EP 0376156-A21990-07-04

    Insulin derivatives, process for their preparation, their use and pharmaceutical compositions containing them.

    HOECHST AKTIENGESELLSCHAFT

    Query Match 18.8%Identity 88.9%

    Best alignment

    Query 73 to 162, hit 180 to 91. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              || || ||||| |||||||||||||| ||||| ||||| || |||||||| |||||||||
    Hit   180 TTCGTCAACCAGCACCTGTGCGGCTCGCACCTCGTGGAGGCCCTCTACCTGGTGTGCGGG 121
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACC 162
              || || |||||||||||||| |||||||||
    Hit   120 GAGCGCGGCTTCTTCTACACCCCCAAGACC 91
    

    79 of 90 identical, no gaps.

  43. JP 2021530210-A2021-11-11

    ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE

    AKSTON BIOSCIENCES CORPORATION

    Query Match 18.3%Identity 88.3%Family of 2

    Best alignment and family

    Query 71 to 161, hit 56 to 146. Positions start at 1 and include both ends.

    Query  71 CCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCG 130
              |||| |||||||| |||||||||||||| |||||||||||||||||  | || |||||||
    Hit    56 CCTTCGTGAACCAGCACCTGTGCGGCTCCCACCTGGTGGAAGCTCTGGAACTCGTGTGCG 115
    
    Query 131 GGGAACGAGGCTTCTTCTACACACCCAAGAC 161
              | || || |||||||||||||| || |||||
    Hit   116 GCGAGCGGGGCTTCTTCTACACCCCTAAGAC 146
    

    79 of 91 identical, no gaps.

    Family of 2

    Grouped by a shared priority claim, US 62/692507.

  44. WO 0210449-A22002-02-07

    Oligonucleotide library for detecting rna transcripts and splice variants that populate a transcriptome

    Compugen Inc. (US)

    Query Match 18.0%Identity 100.0%

    Best alignment

    Query 69 to 128, hit 1 to 60. Positions start at 1 and include both ends.

    Query  69 AGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTG 128
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     1 AGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTG 60
    

    60 of 60 identical, no gaps.

  45. JP 2004508019-A2004-03-18

    OLIGONUCLEOTIDE LIBRARY FOR DETECTING RNA TRANSCRIPTS AND SPLICE VARIANTS THAT POPULATE A TRANSCRIPTOME

    Avi SHOSHAN,Alon WASSERMAN,Eli MINTZ,Liat MINTZ,Simchon FAIGLER

    Query Match 18.0%Identity 100.0%

    Best alignment

    Query 69 to 128, hit 1 to 60. Positions start at 1 and include both ends.

    Query  69 AGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTG 128
              ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
    Hit     1 AGCCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTG 60
    

    60 of 60 identical, no gaps.

  46. US 11667689-B22023-06-06

    Insulin-Fc fusion proteins and methods of use to treat cancer

    Akston Biosciences Corporation

    Query Match 17.7%Identity 86.6%Family of 3

    Best alignment and family

    Query 71 to 159, hit 56 to 144. Positions start at 1 and include both ends.

    Query  71 CCTTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCG 130
              |||| |||||||| |||||||||||||| |||||||||||||||||    || |||||||
    Hit    56 CCTTCGTGAACCAGCACCTGTGCGGCTCCCACCTGGTGGAAGCTCTGGCTCTCGTGTGCG 115
    
    Query 131 GGGAACGAGGCTTCTTCTACACACCCAAG 159
              | || || |||||||||||||| ||||||
    Hit   116 GCGAGCGGGGCTTCTTCTACACCCCCAAG 144
    

    77 of 89 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  47. US 9745359-B22017-08-29

    Protein and protein conjugate for diabetes treatment, and applications thereof

    Query Match 17.6%Identity 93.7%

    Best alignment

    Query 73 to 169, hit 1 to 98. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              ||||| || || ||||| || || || ||||||||||| ||||| ||||| ||||| |||
    Hit     1 TTTGTCAATCAGCACCTTTGTGGTTCTCACCTGGTGGAGGCTCTGTACCTGGTGTGTGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGC-CGGG 169
              ||||| || ||||||||||||||||||||| || ||||
    Hit    61 GAACGTGGTTTCTTCTACACACCCAAGACCGGCTCGGG 98
    

    83 of 98 identical, 1 gap.

  48. US 10472404-B22019-11-12

    Protein and protein conjugate for diabetes treatment, and applications thereof

    ADDA Biotech Inc.

    Query Match 17.6%Identity 93.7%

    Best alignment

    Query 73 to 169, hit 1 to 98. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              ||||| || || ||||| || || || ||||||||||| ||||| ||||| ||||| |||
    Hit     1 TTTGTCAATCAGCACCTTTGTGGTTCTCACCTGGTGGAGGCTCTGTACCTGGTGTGTGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGC-CGGG 169
              ||||| || ||||||||||||||||||||| || ||||
    Hit    61 GAACGTGGTTTCTTCTACACACCCAAGACCGGCTCGGG 98
    

    83 of 98 identical, 1 gap.

  49. US 11208451-B22021-12-28

    Protein and protein conjugate for diabetes treatment, and applications thereof

    Query Match 17.6%Identity 93.7%

    Best alignment

    Query 73 to 169, hit 1 to 98. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              ||||| || || ||||| || || || ||||||||||| ||||| ||||| ||||| |||
    Hit     1 TTTGTCAATCAGCACCTTTGTGGTTCTCACCTGGTGGAGGCTCTGTACCTGGTGTGTGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACCCGC-CGGG 169
              ||||| || ||||||||||||||||||||| || ||||
    Hit    61 GAACGTGGTTTCTTCTACACACCCAAGACCGGCTCGGG 98
    

    83 of 98 identical, 1 gap.

  50. JP 1982009796-A1982-01-19

    ADAPTOR OLIGODEOXYNUCLEOTIDE MOLECULE

    CANADIAN PATENTS & DEV LTD

    Query Match 17.3%Identity 92.1%

    Best alignment

    Query 73 to 162, hit 1 to 90. Positions start at 1 and include both ends.

    Query  73 TTTGTGAACCAACACCTGTGCGGCTCACACCTGGTGGAAGCTCTCTACCTAGTGTGCGGG 132
              ||||| || || ||||| || || || ||||||||||| ||||| ||||| ||||| |||
    Hit     1 TTTGTCAATCAGCACCTTTGTGGTTCTCACCTGGTGGAGGCTCTGTACCTGGTGTGTGGG 60
    
    Query 133 GAACGAGGCTTCTTCTACACACCCAAGACC 162
              ||||| || |||||||||||||||||||||
    Hit    61 GAACGTGGTTTCTTCTACACACCCAAGACC 90
    

    77 of 90 identical, no gaps.